skip to Main Content

Cancer Services

Gastrointestinal Cancer

Please see below all current gastrointestinal cancer clinical trials of the Central Coast Cancer Centre.

Name: CheckMate 577

A Randomized, Multicenter, Double-Blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer.

Protocol Number: CA209577
Principal Investigator: Dr Matthew Wong
Study Coordinator: Leonie Kelly
Status: Recruiting
Condition: Gastrointestinal Cancer
External page link More information about CheckMate 577

Name: INTEGRATE II

A Randomised Phase III Double-Blind Placebo-Controlled Study of regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

Principal Investigator: Dr Matthew Wong
Study Coordinator: Richard Clayton
Status: Recruitment pending
Condition: Gastrointestinal Cancer
External page link More information about INTEGRATE II

Name: BRIGHTER

A Phase III Randomized, Double-blind, Placebo-Controlled Clinical Trial of BBI6608 plus weekly Paclitaxel vc. Placebo plus weekly Paclitaxel in adult Patients with advanced previously treated gastric and Gastro-esophageal Junction Adenocarcinoma.

Protocol Number: BBI608-336
Principal Investigator: Dr Matthew Wong
Study Coordinator: Michelle Dixon
Status: Recruiting
Condition: Gastrointestinal Cancer
External page link More information about BRIGHTER

Name: ASCOLT

ASPIRIN FOR DUKES C AND HIGH-RISK DUKES B COLORECTAL CANCERS
An International, Multi‐centre, Double-Blind, Randomised Placebo-Controlled Phase III Trial

Protocol Number: AG0213CR
Principal Investigator: Dr Matthew Wong
Study Coordinator: Richard Clayton
Status: Recruiting
Condition: Gastrointestinal/Colorectal Cancer
External page link More information about ASCOLT

Name: ATTACHE

A Trial in the Timing of Surgery and Adjuvant Chemotherapy for Hepatic Metastases from Colorectal Cancer

Protocol Number: AG049CL
Principal Investigator: Dr Craig Kukard
Study Coordinator: Leonie Kelly
Status: Closed
Condition: Colorectal Cancer
External page link More information about ATTACHE

Name: FOXFIRE

Global Assessment of Overall Survival of FOLFOX6m plus SIR-Spheres microspheres versus FOLFOX6m alone as first-line treatment in patients with non-resectable liver metastases from primary colorectal carcinoma in a randomised clinical study.

Protocol Number: STX0112
Principal Investigator: Dr Susan Tiley
Study Coordinator: Leonie Kelly
Status: Closed
Condition: Colorectal Cancer
External page link More information about FOLFIRE

Name: Pancreatic cancer Patterns of Care Study (PPOCS)

A protocol for the collection, release and storage of NSW Cancer Council Registry data within Cancer Institute NSW for pancreatic cancer notifications, in years 2010 or 2011 to QLD or NSW Cancer Registries.

Protocol Number: N/A
Principal Investigator: Dr Susan Tiley
Study Coordinator: No Study Coordinator required
Status: Closed
Condition: Pancreatic cancer

More information

For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 3940 or see:

Internal page Research and Clinical Trials

Back To Top